“Biotech is back,” says a recent Jefferies note, as new scientific breakthroughs and underpenetrated markets are unlocking a larger total ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE